Log in to search using one of your social media accounts:

 

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
Conditions:   Systemic Lupus Erythematosus;   Rheumatoid Arthritis Interventions:   Drug: PF-06835375;   Drug: Placebo Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2017 Category: Research Source Type: clinical trials

Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus
Condition:   Quality of Life Intervention:   Behavioral: HRQL Sponsors:   University Hospital Regensburg;   University of Regensburg Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2017 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE
Condition:   Systemic Lupus Erythematosus Interventions:   Drug: Belimumab;   Drug: Rituximab;   Drug: Rituximab-placebo;   Drug: Standard therapy (Including Immunosuppressants);   Drug: Standard therapy (Excluding Immunosuppressants);   Drug: Steriod Taper Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2017 Category: Research Source Type: clinical trials

Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus
Condition:   Lupus Erythematosus, Systemic Intervention:   Drug: Low-dose Aldesleukin (Proleukin®) Sponsor:   Onur Boyman, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2017 Category: Research Source Type: clinical trials